论文部分内容阅读
在中国药学会主办的“规范药品名称与监督管理”药师沙龙上,一些专家认为,用“通用名”开方是一件好事,但如果对此缺乏共识,是难于推广并坚持的。假使技术操作的细节处理不好,急于强行推进,可能会事与愿违。因为药品名称的命名看似简单,其实复杂。其间既有管理问题,也有学术技术问题;既有使用问题,更有市场竞争问题,加之我国药厂众多,仿制药众多,为此,必须建立完善的命名机制,才能彻底解决药品名称混乱问题。药品名称使用上有三个突出问题国家食品药品监督管理局药品注册司司长张伟表示,国家对药品名称有着非常严格的管理规定。但现实中,药品名称在使用上却存在着弱化通用名称、
Some experts believe that using the “common name” is a good thing at the “Standard Drug Name and Supervision” pharmacist’s salon sponsored by the Chinese Pharmaceutical Association. However, if there is a lack of consensus on this, it is difficult to promote and persist of. If the details of technical operations are not handled well and are eager to move forward, things may turn out to be counterproductive. Because the name of the drug name looks simple, in fact, complicated. In the meantime, there are not only administrative problems, but also academic and technical issues. Existing problems of use and market competition have been encountered. In addition, there are many pharmaceutical factories and many generic drugs in our country. To this end, we must establish a sound naming mechanism in order to completely solve the problem of drug name chaos. There are three conspicuous problems in the use of drug names Zhang Wei, director of the Drug Registration Department of the State Food and Drug Administration, said that the state has very strict management rules on the names of drugs. However, in reality, there is a weakening common name in the use of drug names,